Investor List:

Top Diagnostics Series A Investors (13)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Diagnostics investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Shahram Hejazi, Managing Director at BioAdvance
Shahram Hejazi
BioAdvance·Managing Director
Sweet spot: $3.3M
Range: $1.5M - $5.0M
Investors in Princeton (NJ)
Investors in BioTech, Investors in BioTech, Investors in Diagnostics, Investors in Diagnostics, Investors in Digital Health, Investors in Digital Health, Investors in Manufacturing, Investors in Manufacturing, Investors in Medical Devices, Investors in Medical Devices
Photo of Andrew Noyons, Partner at Hambro Perks
Andrew Noyons
Hambro Perks·Partner
Sweet spot: $7.5M
Range: $5.0M - $10.0M
Investors in London
Investors in Diagnostics, Investors in FinTech, Investors in London (Other Lists), Investors in Medical Devices
Photo of Bruce Barron, Partner at Origin Ventures
Bruce Barron
Sweet spot: $3.2M
Range: $500K - $6.0M
Investors in Illinois
Investors in Diagnostics, Investors in Diagnostics, Investors in Digital Health, Investors in Digital Health, Investors in E-commerce, Investors in E-commerce, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Lodging/Hospitality, Investors in Lodging/Hospitality, Investors in Marketplaces, Investors in Marketplaces, Investors in Medical Devices, Investors in Medical Devices
Photo of Kevin Koch, Venture Partner at OrbiMed
Kevin Koch
OrbiMed·Venture Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in San Francisco (CA), Investors in New York
Investors in BioTech, Investors in BioTech, Investors in Colorado / Utah (Other Lists), Investors in Diagnostics, Investors in Diagnostics, Investors in Medical Devices, Investors in Medical Devices
Photo of Peter Thompson, Partner at OrbiMed
Peter Thompson
OrbiMed·Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY), Investors in San Francisco (CA)
Investors in BioTech, Investors in BioTech, Investors in Diagnostics, Investors in Diagnostics, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Pharmaceuticals, Investors in Pharmaceuticals, Investors in Seattle / Portland (Other Lists)
Photo of Iain Dukes, Venture Partner at OrbiMed
Iain Dukes
OrbiMed·Venture Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in BioTech, Investors in BioTech, Investors in Diagnostics, Investors in Diagnostics, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Medical Devices, Investors in Medical Devices, Investors in New York City (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Jon Lim, Partner at F-Prime Capital Partners
Jon Lim
Sweet spot: $5.0M
Range: $100K - $10.0M
Investors in Boston (MA)
Investors in Boston / New England (Other Lists), Investors in Diagnostics, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in SaaS
Photo of Matt Cohen, Partner at Osage University Partners
Matt Cohen
Sweet spot: $7.5M
Range: $5.0M - $10.0M
Investors in Philadelphia (PA)
Investors in Diagnostics, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Medical Devices, Investors in New York City (Other Lists)
Get new data & insights delivered to your inbox